The ESC/EAS Guidelines represent the views of the ESC and EAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication.
First-pass extracted concept
ESC/EAS Guidelines
Candidate: concept label1 source documents3 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
2019 ESC/EAS Guidelines, ESC/EAS dyslipidaemia guidelines
Evidence Snippets
Supporting Sources
Linked Claims
The ESC/EAS Guidelines were produced after careful consideration of the scientific and medical knowledge and evidence available at the time of publication.
Quoted textsource-backed
The ESC/EAS Guidelines represent the views of the ESC and EAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication.
The document presents ESC and EAS guideline views for management of dyslipidaemias and lipid modification to reduce cardiovascular risk.
Quoted textsource-backed
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
The guidelines are intended to inform clinical judgment and implementation of preventive, diagnostic, or therapeutic strategies but do not override clinician responsibility for patient-specific decisions.
Quoted textsource-backed
Health professionals are encouraged to take the ESC/EAS Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC/EAS Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition